Published in Blood on October 01, 1991
Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia (2008) 2.29
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood (2010) 1.79
Dysfunctional T regulatory cells in multiple myeloma. Blood (2005) 1.72
Cytokines involved in the progression of multiple myeloma. Clin Exp Immunol (1993) 0.92
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis. Expert Rev Mol Diagn (2010) 0.87
Immune therapies. Hematol Oncol Clin North Am (2007) 0.81
Hyperreactive cellular immunity in multiple myeloma. Blood (1992) 0.77
CD38 ligation in peripheral blood mononuclear cells of myeloma patients induces release of protumorigenic IL-6 and impaired secretion of IFNγ cytokines and proliferation. Mediators Inflamm (2013) 0.75
Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12
Prediction of difficult mask ventilation. Anesthesiology (2000) 8.31
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
Control of human telomere length by TRF1 and TRF2. Mol Cell Biol (2000) 4.54
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Mapping of genes predisposing to idiopathic generalized epilepsy. Hum Mol Genet (1995) 2.65
Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr Surg (1980) 2.62
Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci (2002) 2.43
Circumumbilical incision for pyloromyotomy. Br J Surg (1986) 1.78
Comparison of phenotypical and molecular methods for the identification of bacterial strains isolated from a deep subsurface environment. Appl Environ Microbiol (1995) 1.75
TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol (1998) 1.73
Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1999) 1.71
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology (1997) 1.63
Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci (2001) 1.62
Tolciclate against dermatophytes. Arzneimittelforschung (1976) 1.62
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys (1988) 1.58
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet (1989) 1.57
Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med (1998) 1.56
In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother (2000) 1.52
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Waardenburg's syndrome associated with total aganglionosis. Arch Dis Child (1983) 1.46
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 1.45
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J (1993) 1.43
[Anaesthetic preoperative assessment of chronic medications and herbal medicine use: a multicenter survey]. Ann Fr Anesth Reanim (2006) 1.41
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med (2000) 1.40
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Implantation of a central venous access device. J R Coll Surg Edinb (1990) 1.38
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood (1992) 1.33
Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant (2001) 1.32
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS (2000) 1.30
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol (1999) 1.26
A Xenopus egg factor with DNA-binding properties characteristic of terminus-specific telomeric proteins. Genes Dev (1993) 1.25
Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis (1995) 1.25
Defective T cell fas function in patients with multiple sclerosis. Neurology (2000) 1.24
The contemporary outcome of gastroschisis. J Pediatr Surg (2000) 1.23
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21
Enumeration of viable bacteria in the marine pelagic environment. Appl Environ Microbiol (1996) 1.19
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
Bacterial diversity in a deep-subsurface clay environment. Appl Environ Microbiol (1996) 1.16
Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome. J Pediatr Surg (2003) 1.15
In-vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother (1990) 1.15
Hernia through iliac crest defects. A report of four cases. Int Orthop (1995) 1.14
Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition. Biochem J (1990) 1.12
Screening of Chlamydia trachomatis genital infection in a young Parisian population. Sex Transm Infect (1999) 1.12
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol (1984) 1.12
Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood (1997) 1.10
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. Haematologica (2001) 1.10
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia (2005) 1.10
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity (1994) 1.10
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia (2011) 1.09
Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur J Immunol (1992) 1.09
Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. Cold Spring Harb Symp Quant Biol (1989) 1.09
Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia (2000) 1.06
Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. Eur J Surg Oncol (2012) 1.06
CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res (1992) 1.06
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life Sci (2005) 1.05
CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol (2000) 1.04
Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial. Support Care Cancer (1996) 1.04
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res (1991) 1.02
GAS6 inhibits granulocyte adhesion to endothelial cells. Blood (1998) 1.02
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treat Rev (1988) 1.02
Altered expression of growth-regulated protooncogenes in human malignant plasma cells. Cancer Res (1989) 1.02
Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematol Oncol Clin North Am (1997) 1.01
Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments. Clin Exp Immunol (1998) 1.01
Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma. Leukemia (1996) 1.01
Multiple peptide synthetase gene clusters in Actinomycetes. Mol Gen Genet (2000) 1.01
Intestinal lengthening: an experimental and clinical review. J R Soc Med (1984) 1.01
Colonic atresia: current results of treatment. J R Coll Surg Edinb (1990) 1.01
Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood (1990) 1.01
Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol (1993) 1.00
Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J Immunol (1996) 1.00
Lessons from the foot and mouth disease outbreak in The Netherlands in 2001. Rev Sci Tech (2002) 1.00
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients. Blood (1999) 0.99
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia (1997) 0.99
Identification of obstructive sites and patterns in obstructive sleep apnoea syndrome by sleep endoscopy in 614 patients. Acta Otorhinolaryngol Ital (2013) 0.99
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood (1999) 0.99
High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study. J Endocrinol Invest (2011) 0.99
Prolonged and monosymptomatic dysphasic status epilepticus. Neurology (1976) 0.99
A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett (2001) 0.98
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon "Grosso" essential oil. Life Sci (2004) 0.98
Pharmacological studies of 'sapo' from the frog Phyllomedusa bicolor skin: a drug used by the Peruvian Matses Indians in shamanic hunting practices. Toxicon (1993) 0.98
Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. J Immunol (1990) 0.98
Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif. Eur J Immunol (2000) 0.97